Keywords: gsk, diversify, yet, derisk, says, new, ceo

GSK will diversify yet "derisk" says new CEO

Article | 23 June 2008

Print This

The UK's leading drug major, GlaxoSmithKline, will broaden the range of its focus from pharmaceuticals while reducing the risk of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in